Health2047, a subsidiary of the American Medical Association (AMA), recently spun out SiteBridge Research to boost clinical trial access for small and community physician practices.

SiteBridge is a portfolio company that aims to create a path towards enriched real-world data and real-world evidence, which ultimately results in more widely applicable clinical trial results.

Additionally, SiteBridge is developing a network of leaders, including physicians and experts engaged with pharmaceuticals. The company will gather these industry perspectives to shape research study design and target more diverse patient representation in clinical trials.